This compound is primarily utilized in pharmaceutical research, particularly in the development of enzyme inhibitors. It has shown potential in targeting specific enzymes involved in disease pathways, making it a candidate for drug discovery efforts. Its structure, featuring a quinoline moiety and a difluoropyrrolidine group, contributes to its ability to interact with biological targets, such as kinases or proteases, which are often implicated in cancer, inflammation, and other disorders. Researchers are exploring its efficacy in preclinical studies to assess its therapeutic potential and optimize its pharmacokinetic properties. Additionally, its unique chemical structure makes it a valuable tool in studying enzyme mechanisms and designing more potent and selective inhibitors.